Pioneer your stem cell research, from basic biological to translational and clinical studies through CRISPR precision editing

The inaugural Precision CRISPR Stem Cell Congress Seattle was founded in partnership with the Allen Institute, will help the large pharma, biotech and academic community overcome efficiency, specificity and delivery challenges to optimise the application of CRISPR gene editing of stem cells.

Showcasing cutting edge data from key opinion leaders who are pushing the boundaries of CRISPR in both basic biological research and translational clinical development of stem cell therapies, discover how to enhance the technical protocols of CRISPR and overcome the scientific difficulties of editing human stem cells and iPS cells.